Suggestions
Michael R. Bishop, M.D.
Director, The David and Etta Jonas Center for Cellular Therapy at University of Chicago
Michael R. Bishop, M.D. is a prominent physician and researcher specializing in hematology, oncology, and cellular therapy at the University of Chicago. Here are some key details about Dr. Bishop:
Professional Roles
Dr. Bishop currently holds several important positions at the University of Chicago:
- Director of the David and Etta Jonas Center for Cellular Therapy
- Director of the Hematopoietic Cellular Therapy Program
- Professor of Medicine in the Division of Hematology and Oncology12
Expertise and Research
Dr. Bishop is an expert in:
- Hematopoietic stem cell transplantation (bone marrow transplantation)
- Cellular therapy
- Treatment of lymphomas and hematologic malignancies
- CAR T-cell therapy and immunotherapy2
His research focuses on developing novel clinical trials in stem cell transplantation and cellular therapy, with particular emphasis on:
- Using T cells to treat blood cancers and solid tumors
- Preventing and treating disease recurrence after stem cell transplantation
- Enhancing the immune effects of transplanted cells against cancer12
Career Highlights
- Joined the National Cancer Institute in 1999 as Clinical Head of the Stem Cell Transplantation Program
- Received tenure as Senior Investigator at NIH in 2007
- Appointed to his current roles at the University of Chicago in 2012 and 2020
- Named a Bucksbaum Institute for Clinical Excellence Master Clinician in 2013
- Consistently named one of the "Best Doctors in America" since 200112
Publications and Leadership
Dr. Bishop has made significant contributions to medical literature, including:
- Authoring over 200 peer-reviewed articles in prestigious journals
- Writing over 35 book chapters on hematologic malignancies and cellular therapy
- Serving on editorial boards of several scientific journals1
His expertise and leadership in the field have earned him recognition and influential roles in various medical societies and organizations.
Highlights
#knowledgesharing Dear Colleagues and Friends, I hope that you will be able to join me and my academic colleagues to here about the latest advances in Leukemia and Lymphoma on June 15, 2023 in downtown Chicago. For those in medical field and are interested, please see the registration link below. Seating is limited. Thanks and take care, Michael
